8 November 2023 in Physics in Medicine & Biology
Purpose . Lymphopenia is a common side effect in patients treated with radiotherapy, potentially caused by direct cell killing of circulating lymphocytes in the blood. To investigate this hypothesis, a method to assess dose to circulating lymphocytes is needed. Methods . A stochastic model to simulate systemic blood flow in the human body was developed based on a previously designed compartment model. Blood dose was obtained by superimposing the spatiotemporal distribution of blood particles with a time-varying dose rate field, and used as a surrogate for dose to circulating lymphocytes. We discuss relevant theory on compartmental modeling and how to combine it with models of explicit organ vasculature. Results . A general workflow was established which can be used for any anatomical site. Stochastic compartments can be replaced by explicit models of organ vasculatures for improved spatial resolution, and tumor compartments can be dynamically assigned. Generating a patient-specific blood flow distribution takes about one minute, fast enough to investigate the effect of varying treatment parameters such as the dose rate. Furthermore, the anatomical structures contributing most to the overall blood dose can be identified, which could potentially be used for lymphocyte-sparing treatment planning. Conclusion . The ability to report the blood dose distribution during radiotherapy is imperative to test and act upon the current paradigm that radiation-induced lymphopenia is caused by direct cell killing of lymphocytes in the blood. We have built a general model that can do so for various treatment sites. The presented framework is publicly available at http://github.com/mghro/hedos .
14 April 2025 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
29 December 2023 in European Journal of Nuclear Medicine and Molecular Imaging
2 May 2023 in Physics in Medicine & Biology
Objective . Phantoms of the International Commission on Radiological Protection provide a framework for standardized dosimetry. The modeling of internal blood vessels—essential to tracking circulating blood cells exposed during external beam radiotherapy and to account for radiopharmaceutical decays while still in blood circulation—is, however, limited to the major inter-organ arteries and veins. Intra-organ blood is accounted for only through the assignment of a homogeneous mixture of parenchyma and blood [single-region (SR) organs]. Our goal was to develop explicit dual-region (DR) models of intra-organ blood vasculature of the adult male brain (AMB) and adult female brain (AFB). Approach . A total of 4000 vessels were created amongst 26 vascular trees. The AMB and AFB models were then tetrahedralized for coupling to the PHITS radiation transport code. Absorbed fractions were computed for monoenergetic alpha particles, electrons, positrons, and photons for both decay sites within the blood vessels and for tissues outside these vessels. Radionuclide S -values were computed for 22 and 10 radionuclides commonly employed in radiopharmaceutical therapy and nuclear medicine diagnostic imaging, respectively. Main results . For radionuclide decays, values of S (brain tissue ← brain blood) assessed in the traditional manner (SR) were higher than those computed using our DR models by factors of 1.92, 1.49, and 1.57 for therapeutic alpha-emitters, beta-emitters, and Auger electron-emitters, respectively in the AFB and by factors of 1.65, 1.37, and 1.42 for these same radionuclide categories in the AMB. Corresponding ratios of SR and DR values of S (brain tissue ← brain blood) were 1.34 (AFB) and 1.26 (AMB) for four SPECT radionuclides, and were 1.32 (AFB) and 1.24 (AMB) for six common PET radionuclides. Significance . The methodology employed in this study can be explored in other organs of the body for proper accounting of blood self-dose for that fraction of the radiopharmaceutical still in general circulation.
19 June 2025 in Physics in Medicine & Biology
Objective. To develop a computational framework coupling multiscale vascular models of the human liver for improved radiation dosimetry calculations that clearly distinguish the absorbed dose to tissue parenchyma and that to its blood content at all spatial scales. This framework thus addresses limitations of homogeneous blood/tissue organ models in present use in radiopharmaceutical therapy. Approach. High-fidelity tetrahedral mesh models of liver vasculature were constructed at two spatial scales. At the macroscale, detailed hepatic arterial, venous, and portal venous networks were generated within reference adult male and female computational phantoms. At the microscale, a classical hexagonal liver lobule model incorporating sinusoids, bile compartments, and cellular components was developed. A mathematical framework was further developed to couple Monte Carlo radiation transport results across these spatial scales, enabling comprehensive dosimetric calculations for radiation dose to both blood and parenchymal tissues. Main Results. The coupled model system successfully accounted for the entire blood content of the liver, with approximately 31% represented in macroscale vessels (⩾100 μm diameter) and 69% within microscale structures. Specific absorbed fractions were computed for monoenergetic photons, electrons, and alpha particles, demonstrating reciprocity between blood-to-parenchyma and parenchyma-to-blood crossfire. Reference S-values were computed for 22 therapeutic and 11 diagnostic radionuclides, providing the first comprehensive dataset for blood-specific and parenchyma-specific internal dosimetry calculations in the liver. Significance. This work establishes a novel framework for multi-scale radiation transport calculations in vascularized organs, enabling separate tracking of blood and parenchymal tissue doses. The methodology has immediate applications in improving dose calculations for radiopharmaceutical therapies, Y-90 microsphere radioembolization treatment, and analysis of blood dose during external beam radiotherapy. The approach can be readily adapted for other vascularized organs, representing a significant advancement in radiation dosimetry accuracy for both therapeutic and diagnostic applications by fully and independently accounting for organ activity localized within two tissue compartments—organ blood and organ parenchyma.
15 April 2026 in Physics in Medicine & Biology
Objective: To introduce FLIP-HEDOS, a blood dose modeling framework that combines patient-specific and generic circulatory data to enable individualized blood dose estimation during radiotherapy treatments and to overcome limitations of non-personalized approaches. Approach: Patient-specific images of vasculature were obtained from patients with thorax-abdomen or head-neck tumors treated with proton or photon radiotherapy. Large vessels from the tumor location were segmented, and their blood flow velocities were extracted from phase-contrast MRI. Movement of blood particles (BPs) was simulated using a Lagrangian approach along patient-specific flowlines in these vessels, forming the FLIP method. This circulation was incorporated into a standardized model (HEDOS) to form a closed-loop whole-body model that computes the spatiotemporal BP distribution and associated blood dose accumulation, accounting for dose delivery dynamics, dose rate and beam-on/beam-off times. Cardiac output was individualized to match each patient blood flow characteristics. FLIP-HEDOS retains the modular HEDOS architecture, extending its large vessel compartments with the FLIP approach patient-specific vessels represented as new compartments. Remaining compartments were adapted to preserve the standardized connectivity of the circulatory network. Main results: The study quantified mean blood dose values and tracked the number of times BPs entered patient-specific compartments during dose delivery. Simulations were performed across a range of inter-beam intervals, and the three models FLIP (patient-specific vessels), HEDOS (generic whole-body), and FLIP-HEDOS (integrated model) were compared with respect to their resulting blood dose values. The comparison shows that when patient-specific information is incorporated in blood dose assessment, BPs experience higher radiation doses. Significance: FLIP-HEDOS proves that standardized vascular data can be effectively combined with patient-specific parameters to achieve physiologically realistic modeling of circulating blood. By enabling individualized cardiac output and blood flow dynamics, the framework adapts to the anatomical and hemodynamic characteristics of each patient.